Jamshed Haneef | Toxicology and Pharmaceutical Science | Innovative Research Award

Published on by Invention Awards

Innovative Research Award

Jamshed Haneef
Jamia Hamdard

Jamshed Haneef
Affiliation Jamia Hamdard
Country India
Scopus ID 55675642900
Documents 36
Citations 566
h-index 14
Subject Area Toxicology and Pharmaceutical Science
Event International Invention Awards
ORCID 0000-0002-5520-6466

Jamshed Haneef is a researcher affiliated with Jamia Hamdard, India, whose supplied bibliometric profile identifies toxicology as the subject area. The reported Scopus record includes 36 documents, 566 citations and an h-index of 14. These indicators provide a quantitative overview of the publication and citation record associated with the identified author profile. The Innovative Research Award provides a recognition framework for examining research originality, methodological quality, scientific contributions and potential applications. This article presents the supplied profile information and discusses relevant considerations for evaluating research achievements without assuming unverified award decisions or attributing specific inventions to the researcher. [1]

Abstract

This article presents a research-profile overview of Jamshed Haneef, affiliated with Jamia Hamdard, India, with toxicology identified as the principal subject area in the supplied information. The reported Scopus metrics comprise 36 documents, 566 citations and an h-index of 14. These measures describe aspects of scholarly productivity and citation visibility but do not independently establish research quality, originality or practical impact. The profile is considered in the context of the Innovative Research Award associated with the International Invention Awards. Assessment of research distinction requires examination of verified publications, individual contributions, methodological rigor, innovation evidence and potential societal relevance. [1] [2]

Keywords

Jamshed Haneef; Innovative Research Award; International Invention Awards; Jamia Hamdard; India; toxicology; research evaluation; bibliometrics; scientific publications; citation analysis; h-index; research innovation; scholarly impact; research assessment.[1]

Introduction

Research recognition can help communicate scientific achievements and draw attention to work with potential value for academic or practical applications. In toxicology, research may address the effects of chemical, biological or environmental agents on living systems, including mechanisms of toxicity, exposure assessment and risk evaluation. Evaluating a researcher’s contributions requires consideration of the relevance and reliability of the underlying studies, alongside publication and citation information. [3]

Research Profile

Jamshed Haneef is listed in the supplied profile data as affiliated with Jamia Hamdard in India. The stated subject area is toxicology, a field concerned with the adverse effects of substances and the scientific assessment of exposure-related risks. The reported bibliometric indicators are 36 documents, 566 citations and an h-index of 14. The Scopus author identifier and ORCID supplied for this profile provide starting points for checking identity and publication records. [1] [4]

Research Contributions

Research contributions in toxicology may include identifying mechanisms of toxicity, characterizing hazardous exposures, evaluating biological responses and developing methods that improve safety assessment. Such work can support scientific understanding and inform decisions in areas including environmental health, pharmaceutical development and chemical risk management. The relevance of any contribution should be established through the researcher’s actual publications, study designs and documented findings rather than inferred solely from a subject-area label. [3]

Publications

The supplied Scopus profile reports 36 documents associated with the author identifier 55675642900. This count offers a broad indication of indexed scholarly output, but a complete publication review would need to establish the document types, publication dates, subject relevance and authorship details. A verified bibliography should be checked against the original publisher records and the researcher’s persistent identifiers to reduce the risk of author-name ambiguity.[5]

Research Impact

The reported 566 citations indicate that documents associated with the supplied profile have received scholarly citations within the relevant indexing record. The h-index of 14 represents a combined measure of publication output and citation distribution under the standard definition: at least 14 indexed publications have each received at least 14 citations, assuming the supplied metrics are accurate and refer to the same author record. These values can help describe scholarly visibility but may vary by database, coverage and retrieval date. [2]

Award Suitability

The Innovative Research Award, presented here in the context of the International Invention Awards, can be assessed through evidence of originality, research rigor, individual contribution and the potential value of the work. The reported publication and citation indicators offer useful background information, but award suitability cannot be established from bibliometric metrics alone. A fair evaluation would examine the candidate’s actual research outputs, the significance of the findings and the strength of supporting evidence.[5]

Conclusion

The supplied profile describes Jamshed Haneef as affiliated with Jamia Hamdard, India, and identifies toxicology as the subject area. It reports 36 documents, 566 citations and an h-index of 14 under the specified Scopus author identifier. These indicators provide a starting point for understanding the research record, but a comprehensive evaluation should also consider the content, rigor, originality and practical significance of individual contributions. Any formal recognition associated with the Innovative Research Award should be supported by verified award records and primary research documentation.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Jamshed Haneef, Author ID 55675642900.
    https://www.scopus.com/authid/detail.uri?authorId=55675642900
  2. Journal article. (2023). Structural insights into mechanical anisotropy in ambrisentan polymorphs.
    https://doi.org/10.1039/d3ce00483j
  3. Journal article. (2022). Investigation of a Minocycline-Loaded Nanoemulgel for the Treatment of Acne Rosacea.
    https://doi.org/10.3390/pharmaceutics14112322
  4. ORCID. (n.d.). ORCID record: 0000-0002-5520-6466.
    https://orcid.org/0000-0002-5520-6466
  5. International Invention Awards. (2026.). Official award website.
    https://inventionawards.org/

Hamid Madanchi | Toxicology and Pharmaceutical Science | Best Researcher Award

Published on by Invention Awards

Best Researcher Award

Hamid Madanchi
Semnan University of Medical Sciences

Hamid Madanchi
Affiliation Semnan University of Medical Sciences
Country Iran
Scopus ID 55053356700
Documents 88
Citations 1,964
h-index 25
Subject Area Toxicology and Pharmaceutical Science
Event International Invention Awards
ORCID 0000-0002-6527-7321

Hamid Madanchi is presented in this academic recognition profile in connection with the Best Researcher Award at the International Invention Awards. His stated institutional affiliation is Semnan University of Medical Sciences in Iran, and his designated subject area is Toxicology and Pharmaceutical Science. The supplied bibliometric information includes 88 documents, 1,964 citations, and an h-index of 25. These figures provide a quantitative overview of the reported research record but should be interpreted in the context of publication quality, research contributions, authorship, and independent verification. The profile brings together researcher identification, scholarly activity, research impact, and award suitability within a structured academic overview. [1]

Abstract

This profile presents Hamid Madanchi in the context of the Best Researcher Award associated with the International Invention Awards. His stated affiliation is Semnan University of Medical Sciences, Iran, and his subject area is Toxicology and Pharmaceutical Science. The supplied academic indicators comprise 88 documents, 1,964 citations, and an h-index of 25. These metrics offer an initial quantitative perspective on reported scholarly activity, although their accuracy and interpretation require confirmation through authoritative bibliographic records. A comprehensive assessment should also examine publication quality, individual research contributions, methodological rigor, scientific relevance, collaboration, and potential benefits to pharmaceutical and toxicological research.[2]

Keywords

Hamid Madanchi; Best Researcher Award; International Invention Awards; Semnan University of Medical Sciences; Iran; toxicology; pharmaceutical science; bibliometrics; research evaluation; scholarly publications; citation analysis; h-index; scientific recognition; research impact; academic achievement.[1]

Introduction

Researcher recognition provides an opportunity to communicate scientific contributions, professional affiliations, and evidence of scholarly activity. In toxicology and pharmaceutical science, research may contribute to understanding chemical safety, drug development, pharmacological mechanisms, exposure assessment, and therapeutic evaluation. Assessing a researcher’s work therefore requires consideration of both quantitative indicators and the scientific substance of individual studies. Bibliographic databases support discovery and evaluation, but their records may contain incomplete affiliations, duplicate entries, or author-identification ambiguities.[3]

Research Profile

Hamid Madanchi is identified in the supplied information as a researcher affiliated with Semnan University of Medical Sciences in Iran. Toxicology and Pharmaceutical Science is the designated subject area for this profile. Establishing a complete research profile requires connecting the author’s identity with verified institutional records, indexed publications, and persistent researcher identifiers. Scopus provides author records and bibliographic information, while ORCID offers a persistent identifier intended to distinguish researchers and connect their scholarly contributions. [1] [2]

Research Contributions

Research contributions in toxicology and pharmaceutical science can be assessed through their scientific questions, experimental or analytical methods, reproducibility, and relevance to medicine or public health. Relevant work may investigate the safety of chemical substances, biological responses to exposure, drug efficacy, adverse effects, or the development of improved pharmaceutical approaches. These are general dimensions of the subject area and should not be interpreted as a list of specific findings attributed to Hamid Madanchi without verified publications. [3]

Publications

The supplied profile reports 88 documents associated with the Scopus author identifier 55053356700. This number is presented as user-provided information and has not been independently confirmed for this article. A complete publication bibliography should be assembled from the linked author record and cross-checked against article titles, author lists, journal information, publication years, and persistent identifiers such as digital object identifiers (DOIs). [1]

Research Impact

The supplied bibliometric figures are 1,964 citations and an h-index of 25, alongside 88 reported documents. The h-index is a measure that combines publication output and citation counts: a researcher has an h-index of 25 when at least 25 indexed publications have each received at least 25 citations within the database and date of assessment. Citation totals and h-index values vary across databases, coverage periods, and author-disambiguation methods, so these indicators should be interpreted alongside the underlying records. [4]

Award Suitability

The Best Researcher Award profile places emphasis on scholarly output, research influence, disciplinary relevance, and evidence of sustained academic activity. The supplied document count, citation total, and h-index offer potential quantitative indicators for consideration. However, eligibility and final award suitability cannot be established by bibliometric measures alone. A fair assessment should also examine verified publications, originality, research integrity, the significance of documented contributions, and compliance with the award’s published evaluation criteria.[1]

Conclusion

This article presents an academic recognition profile for Hamid Madanchi, identified with Semnan University of Medical Sciences in Iran and the subject area of Toxicology and Pharmaceutical Science. The supplied record lists 88 documents, 1,964 citations, and an h-index of 25. These indicators provide a starting point for understanding reported scholarly activity but require confirmation against authoritative database records. A reliable final assessment should combine bibliometric evidence with publication-level review, documented individual contributions, research quality, and transparent award criteria. The profile is intended as a structured reference for academic communication rather than an independent certification of the reported metrics.[3]

References

  1. Elsevier. (n.d.). Scopus: Abstract and citation database and author profiles.
    https://www.scopus.com/authid/detail.uri?authorId=55053356700
  2. ORCID. (n.d.). ORCID: Connecting research and researchers.
    https://orcid.org/0000-0002-6527-7321
  3. Journal article. (2021.). RETRACTED ARTICLE: Chitosan hydrogel/silk fibroin/Mg(OH)2 nanobiocomposite as a novel scaffold with antimicrobial activity and improved mechanical properties.
    https://doi.org/10.1038/s41598-020-80133-3
  4. Journal article. (2021.). In Vitro Targeting of NL2 Peptide Bounded on Poly L-DOPA Coated Graphene Quantum Dot.
    https://doi.org/10.1007/s10895-020-02660-6
  5. International Invention Awards. (2026.). Official award website.
    https://inventionawards.org/

Ziqin Wang | Toxicology and Pharmaceutical Science | Innovative Research Award

Published on by Invention Awards

Innovative Research Award

Ziqin Wang
Beijing Chaoyang Kaiwen Academy

Researcher Profile
Affiliation Beijing Chaoyang Kaiwen Academy
Country China
Subject Area Toxicology and Pharmaceutical Science
Event International Invention Awards
ORCID 0009-0004-2036-3316

Ziqin Wang is associated with Beijing Chaoyang Kaiwen Academy in China, with toxicology and pharmaceutical science identified as the relevant subject areas in the supplied profile. These disciplines investigate the biological effects of chemical substances, pharmaceutical safety, therapeutic development, and evidence-based approaches to evaluating medicines.methodological quality, and research relevance. Specific publications, research achievements, and bibliometric indicators require independent verification before attribution. Established toxicological assessment principles and pharmaceutical research guidance provide a foundation for evaluating scientific contributions in these fields.[1][2]

Abstract

This article presents an academic recognition profile for Ziqin Wang of Beijing Chaoyang Kaiwen Academy, China, in connection with the Innovative Research Award and the International Invention Awards. The stated subject areas are toxicology and pharmaceutical science, which encompass chemical safety, biological responses, therapeutic substances, and pharmaceutical development. The profile outlines relevant research themes and describes considerations for evaluating originality, methodological quality, scientific integrity, and practical relevance. Specific publications, research achievements, citation counts, and other bibliometric indicators have not been independently verified. Authoritative institutional records and scholarly databases should be consulted before attributing individual accomplishments or drawing conclusions about research impact or award eligibility.

Keywords

Ziqin Wang, Innovative Research Award, International Invention Awards, toxicology, pharmaceutical science, drug safety, pharmacological research, chemical risk assessment, pharmaceutical innovation, scientific research, biomedical development, research evaluation.

Introduction

Scientific innovation advances knowledge by introducing new methods, testing hypotheses, and addressing unresolved research questions. Toxicology and pharmaceutical science contribute to this process through investigations of chemical hazards, biological mechanisms, drug safety, and therapeutic development. Evaluating work in these areas requires attention to experimental design, reproducibility, ethical conduct, and the strength of supporting evidence. Internationally recognized scientific and pharmaceutical guidance provides useful context for understanding these requirements.[1][2]

Research Profile

The supplied information identifies Ziqin Wang with Beijing Chaoyang Kaiwen Academy in China and lists toxicology and pharmaceutical science as relevant subject areas. These fields combine concepts from chemistry, biology, pharmacology, and health sciences to examine the effects of substances and the development of therapeutic products. The available information does not independently establish a specific research appointment, degree, laboratory affiliation, or publication history. Additional details should be confirmed through institutional documentation, scholarly records, or the researcher’s verified public profile before inclusion in a formal academic biography.[3]

Research Contributions

Potential contributions within toxicology and pharmaceutical science include the assessment of chemical hazards, analysis of dose-response relationships, investigation of biological mechanisms, and development of improved methods for evaluating substance safety. Pharmaceutical research can also address formulation, drug delivery, analytical techniques, and the evaluation of therapeutic candidates. These examples describe the broader scientific disciplines and should not be interpreted as confirmed achievements by Ziqin Wang. Individual discoveries, inventions, experimental results, or original methods should be attributed only when supported by identifiable publications, patents, institutional records, or other reliable evidence.[1][2]

Publications

A verified publication record helps establish research activity, subject expertise, and scholarly contributions. Relevant materials may include peer-reviewed journal articles, conference papers, research reports, and publications describing original experimental findings. Each record should be checked for authorship, publication details, journal information, and a persistent identifier such as a digital object identifier (DOI), when available. No specific publication or DOI has been verified for this profile. Consequently, publication titles and numerical research indicators should be added only after checking appropriate scholarly databases and original publication records.[3]

Research Impact

Research impact can be examined through scientific quality, reproducibility, independent citation, practical application, and relevance to important research questions. In toxicology and pharmaceutical science, meaningful outcomes may include stronger safety assessment methods, improved understanding of biological effects, or evidence that supports further therapeutic development. Citation counts and h-index values can indicate aspects of scholarly visibility but cannot independently establish originality or practical benefit. An evidence-based assessment of Ziqin Wang’s research impact requires verified publications, documented research outputs, and independent evidence of how the work has contributed to scientific understanding or subsequent applications.[1]

Award Suitability

The Innovative Research Award provides a framework for recognizing work that may demonstrate originality, methodological rigor, scientific relevance, and responsible innovation. In toxicology and pharmaceutical science, a nomination may be supported by documented research findings, validated methods, relevant publications, patents, or evidence of practical application. The supplied profile information alone is insufficient to establish award eligibility or determine the strength of a nomination. A fair assessment should use the International Invention Awards’ applicable eligibility requirements and evaluation criteria, supported by reliable documentation and a transparent review process.[3]

Conclusion

This profile presents Ziqin Wang in the context of Beijing Chaoyang Kaiwen Academy, China, and the subject areas of toxicology and pharmaceutical science. It outlines the broader scientific context of the Innovative Research Award and the importance of originality, reproducibility, and evidence-based evaluation. A complete academic assessment requires verified scholarly outputs, documented research achievements, and confirmation of the relevant award criteria. The inclusion of numbered references links the discussion to sources on toxicological assessment, pharmaceutical guidance, and researcher identification, while maintaining a clear distinction between supplied profile information and independently established facts.

References

  1. ORCID. (n.d.). ORCID: Connecting Research and Researchers. ORCID.
    https://orcid.org/0009-0004-2036-3316
  2. Journal article. (2026. ) Cardiolipin-Specific Targeting of Melittin via Arg22 in Lipid Membranes: A Natural Toxin-Based Strategy for Treating Mitochondrial Dysfunction in Aging and Disease.
    https://doi.org/10.3390/toxins18100432
  3. International Invention Awards. (2026.). Official website.
    https://inventionawards.org/

Rupa Mazumder | Toxicology and Pharmaceutical Science | Best Researcher Award

Published on by Invention Awards

Best Researcher Award

Rupa Mazumder
Noida Institute of Engineering And Technology

Rupa Mazumder
Affiliation Noida Institute of Engineering And Technology
Country India
Scopus ID 7005832705
Documents 211
Citations 1,412
h-index 18
Subject Area Toxicology and Pharmaceutical Science
Event International Invention Awards
ORCID 0000-0002-1888-548X

Rupa Mazumder is a researcher affiliated with the Noida Institute of Engineering And Technology, India, whose documented scholarly profile is associated with toxicology and pharmaceutical science. The supplied Scopus record reports 211 documents, 1,412 citations, and an h-index of 18, providing a bibliometric basis for considering the researcher within an academic recognition framework. [1]

Abstract

Rupa Mazumder is an India-based researcher affiliated with the Noida Institute of Engineering And Technology and associated with the subject area of Toxicology and Pharmaceutical Science. The supplied bibliometric profile records 211 scholarly documents, 1,412 citations, and an h-index of 18. These indicators provide measurable evidence of sustained research activity and scholarly visibility. Her profile is considered in relation to the Best Researcher Award under the International Invention Awards framework. Assessment of researcher recognition may consider publication productivity, citation influence, research continuity, subject expertise, and the broader relevance of scientific contributions. Bibliometric information should be interpreted alongside verified qualitative evidence and individual research outputs for balanced academic evaluation.

Keywords

Rupa Mazumder; Best Researcher Award; Toxicology; Pharmaceutical Science; Drug Research; Pharmacology; Research Impact; Scholarly Publications; Citation Analysis; h-index; Scientific Research; International Invention Awards.

Introduction

Researcher recognition in pharmaceutical and toxicological sciences commonly involves consideration of scholarly productivity, research quality, citation performance, and sustained engagement with scientific questions. Bibliometric indicators can provide a structured quantitative perspective, although they do not independently establish the originality or practical significance of individual studies. The available profile for Rupa Mazumder presents a substantial publication and citation record that can be examined as part of a broader academic assessment. [1] Standardized researcher identifiers such as Scopus Author ID and ORCID can also assist in distinguishing scholarly outputs and improving the reliability of attribution. [2]

Research Profile

The supplied profile identifies Rupa Mazumder with the Noida Institute of Engineering And Technology in India and places the research activity within Toxicology and Pharmaceutical Science. The reported Scopus Author ID is 7005832705, while the associated ORCID is 0000-0002-1888-548X. These persistent identifiers provide complementary mechanisms for connecting scholarly records with an individual researcher and can support verification across academic databases. [1] [2]

Research Contributions

Within toxicology and pharmaceutical science, research contributions may encompass the investigation of drug effects, safety, pharmacological mechanisms, toxicological responses, therapeutic development, and related biomedical questions. The available information does not provide a complete thematic inventory of Rupa Mazumder’s individual studies, so specific scientific claims should be based on verified publication records rather than inferred solely from bibliometric indicators. The documented publication volume nevertheless indicates sustained participation in scholarly research. [1]

Publications

The supplied Scopus information records 211 documents associated with the researcher profile. Publication counts are useful for describing research productivity but should be evaluated with attention to document type, authorship, journal quality, research field, chronology, and subject relevance. A complete publication assessment would require examination of the underlying indexed records and individual bibliographic metadata. The reported document count is therefore presented as a profile-level bibliometric indicator rather than as an independent measure of research quality. [1]

Research Impact

The supplied profile reports 1,412 citations and an h-index of 18. Citation indicators can help describe the visibility and scholarly uptake of published research, while the h-index combines productivity and citation dimensions into a single metric. Such measures vary across disciplines, career stages, database coverage, and publication practices and should therefore be interpreted within appropriate academic context. [1] Citation-based assessment is strongest when complemented by qualitative evidence concerning originality, methodological contribution, collaboration, and influence on subsequent research.

Award Suitability

The available bibliometric information provides a relevant quantitative foundation for consideration for the Best Researcher Award. The combination of 211 reported documents, 1,412 citations, and an h-index of 18 indicates an established scholarly record within the supplied profile. [1] Final award suitability should, however, be determined through verification of the researcher identity, publication record, research quality, originality, professional contributions, and alignment with the applicable award criteria. The profile therefore supports consideration without implying that bibliometric measures alone determine award outcome.

Conclusion

Rupa Mazumder’s supplied academic profile documents substantial scholarly activity in the field of Toxicology and Pharmaceutical Science, with 211 documents, 1,412 citations, and an h-index of 18. These indicators establish a useful quantitative basis for academic recognition while requiring contextual interpretation. [1] Verification through persistent researcher identifiers, indexed publications, and qualitative evidence can strengthen the assessment. On the information provided, the profile presents a credible basis for consideration under the Best Researcher Award category of the International Invention Awards.

References

  1. Elsevier. (n.d.). Scopus author details: Rupa Mazumder, Author ID 7005832705. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=7005832705
  2. ORCID. (n.d.). ORCID record: Rupa Mazumder, ORCID 0000-0002-1888-548X. ORCID.
    https://orcid.org/0000-0002-1888-548X
  3. Journal article. (2026).Preparations, Applications, Patents, and Marketed Formulations of Nanoemulsions – A Comprehensive Review.
    http://dx.doi.org/10.2174/0122117385325186240912110731
  4. Journal article. (2025). A Comprehensive Investigation on the Role of Bioactives on DYRK1A to Avert Alzheimer’s Disease.
    https://doi.org/10.18311/jnr/2025/49903
  5. International Invention Awards. (2026. ). Official award website.
    https://inventionawards.org/

Stephen Chelko | Toxicology and Pharmaceutical Science | Innovative Research Award

Published on by Invention Awards

Innovative Research Award

Stephen Chelko
Florida State University College of Medicine

Stephen Chelko
Affiliation Florida State University College of Medicine
Country United States
Scopus ID 54973874200
Documents 47
Citations 1,649
h-index 18
Subject Area Toxicology and Pharmaceutical Science
Event International Invention Awards
ORCID 0000-0003-1675-5945

Stephen Chelko is a researcher affiliated with the Florida State University College of Medicine whose documented scholarly profile is associated with toxicology and pharmaceutical science. Available bibliometric information records 47 documents, 1,649 citations, and an h-index of 18, providing a quantitative basis for assessing research visibility and scholarly influence. [1]

Abstract

Stephen Chelko is a researcher associated with Florida State University College of Medicine and the fields of toxicology and pharmaceutical science. His indexed scholarly record comprises 47 documents, 1,649 citations, and an h-index of 18, according to the supplied Scopus profile information. These indicators provide a measurable basis for describing his research visibility and citation impact within scholarly databases. His profile may be considered in the context of recognition for innovative research, particularly where scientific investigation, translational relevance, and contribution to biomedical knowledge are central criteria. The Innovative Research Award provides a framework for highlighting documented scholarly achievement and research significance.

Keywords

Stephen Chelko; Innovative Research Award; toxicology; pharmaceutical science; biomedical research; Florida State University College of Medicine; research impact; scholarly publications; citation analysis; translational science.

Introduction

Academic recognition commonly considers the quality, relevance, originality, and influence of a researcher’s scholarly work. In this context, Stephen Chelko’s documented profile combines research activity in toxicology and pharmaceutical science with measurable bibliometric indicators. The available Scopus record identifies 47 documents, 1,649 citations, and an h-index of 18. [1]

Research Profile

Chelko’s stated subject area is Toxicology and Pharmaceutical Science, positioning his scholarly profile within disciplines concerned with biological effects, therapeutic development, pharmaceutical research, and related biomedical questions. His affiliation with Florida State University College of Medicine further places this work within an academic medical environment. [4]

Research Contributions

The available information supports describing Chelko’s contribution through his documented publication record and citation footprint rather than assigning unsupported claims about individual discoveries. Forty-seven indexed documents indicate sustained scholarly output, while the recorded citation count suggests that his published research has been referenced by subsequent academic literature. [1]

Publications

The supplied researcher profile reports 47 documents indexed in Scopus. Because complete publication titles, journals, publication years, and article-level DOI information were not supplied, this page does not attribute individual papers or DOI records without verification. The Scopus author profile provides the appropriate source for reviewing the complete indexed publication record. [1]

Research Impact

Research impact can be assessed through several complementary dimensions, including scholarly citations, publication continuity, disciplinary relevance, and potential contribution to scientific practice. Chelko’s reported 1,649 citations and h-index of 18 provide quantitative indicators of scholarly visibility, although bibliometric measures should be interpreted alongside qualitative assessment of research originality and significance. [1]

Award Suitability

The documented research profile is relevant to an Innovative Research Award because it demonstrates sustained scholarly activity in a biomedical subject area and a measurable citation record. Final award suitability should nevertheless depend on the official nomination criteria, verified publications, originality of contributions, supporting evidence, and independent evaluation by the responsible award committee. [5]

Conclusion

Stephen Chelko’s supplied academic profile presents a researcher working in toxicology and pharmaceutical science, affiliated with Florida State University College of Medicine. The reported record of 47 documents, 1,649 citations, and an h-index of 18 provides a measurable foundation for academic recognition. These indicators should be considered together with verified research quality and innovation.

References

  1. Elsevier. (n.d.). Scopus author details: Stephen Chelko, Author ID 54973874200. Scopus.
    https://www.scopus.com/pages/authors/54973874200
  2. ORCID. (n.d.). Stephen Chelko, ORCID iD 0000-0003-1675-5945. ORCID.
    https://orcid.org/0000-0003-1675-5945
  3. Google Scholar. (n.d.). Stephen Chelko — Google Scholar profile.
    https://scholar.google.com/citations?hl=en&user=5Hq6SM0AAAAJ
  4. Journal article. (2019.). Therapeutic Modulation of the Immune Response in Arrhythmogenic Cardiomyopathy.
    https://doi.org/10.1161/CIRCULATIONAHA.119.040676
  5. International Invention Awards. (2026.). Official Award Information.
    https://inventionawards.org/